Direct comparison of BLM-CM-induced CD14+ cDC2s from HDs with CD14+ cDC2s isolated from NSCLC patients, both cultured for 3 days, reveals a high level of similarity as well with only HLA-DR and CD163 significantly different on BLM-CM-induced CD14+ cDC2s (Figure S5B). The gene discussed is CD163; the disease is non-small cell lung carcinoma.